The United States might transfer a step nearer to approving the Pfizer-Biontech Covid vaccine on Thursday, because the Food and Drug Administration’s advisers meet to debate its authorisation.
But how will Americans get it? Will it’s free? And will sufficient individuals take it?
BBC international well being correspondent Smitha Mundasad explains.